Published in
American Society of Hematology, Blood, 20(129), p. 2808-2810
DOI: 10.1182/blood-2017-02-765115
Links
Tools
Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059
Journal article published in 2017 by
Harriet S. Walter 
,
Sandrine Jayne ,
Simon A. Rule ,
Guillaume Cartron ,
Franck Morschhauser ,
Salvador Macip ,
Lionel Karlin,
Ceri Jones,
Charles Herbaux,
Philippe Quittet,
Nimish Shah,
Claire V. Hutchinson,
Christopher Fegan ,
Yingsi Yang,
Siddhartha Mitra
and other authors.
,
Sandrine Jayne ,
Simon A. Rule ,
Guillaume Cartron ,
Franck Morschhauser ,
Salvador Macip ,
Lionel Karlin,
Ceri Jones,
Charles Herbaux,
Philippe Quittet,
Nimish Shah,
Claire V. Hutchinson,
Christopher Fegan ,
Yingsi Yang,
Siddhartha Mitra
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 